Search Results Search Sort by RelevanceMost Recent Viewpoint Mar 2016 Undocumented Immigrants Face a Unique Set of Risks from Tuberculosis Treatment: Is This Just? Kelly A. Kyanko, MD, MHS, Jun-Chieh James Tsay, MD, MSc, Katherine Yun, MD, MHS, and Brendan Parent, JD Undocumented immigrants treated with isoniazid (INH) for latent tuberculosis infection should be covered for transplant for INH-related liver failure. AMA J Ethics. 2016;18(3):311-318. doi: 10.1001/journalofethics.2016.18.3.sect1-1603. Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 1 Mary Jane Massie, MD Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502. Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 2 Johannes Gobertus Meran, MD, MA Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502. Case and Commentary Jul 2005 When Diagnosis Becomes Unaffordable, Commentary 1 William Hensel, MD Virtual Mentor. 2005;7(7):457-460. doi: 10.1001/virtualmentor.2005.7.7.ccas1-0507. Case and Commentary Jul 2005 When Diagnosis Becomes Unaffordable, Commentary 2 Justin List, MAR Virtual Mentor. 2005;7(7):460-463. doi: 10.1001/virtualmentor.2005.7.7.ccas1-0507 Case and Commentary Aug 2005 Disclosing Error to a Patient: Physician-to-Patient Communication Geoffrey H. Gordon, MD Virtual Mentor. 2005;7(8):537-540. doi: 10.1001/virtualmentor.2005.7.8.ccas1-0508. Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411. State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
Viewpoint Mar 2016 Undocumented Immigrants Face a Unique Set of Risks from Tuberculosis Treatment: Is This Just? Kelly A. Kyanko, MD, MHS, Jun-Chieh James Tsay, MD, MSc, Katherine Yun, MD, MHS, and Brendan Parent, JD Undocumented immigrants treated with isoniazid (INH) for latent tuberculosis infection should be covered for transplant for INH-related liver failure. AMA J Ethics. 2016;18(3):311-318. doi: 10.1001/journalofethics.2016.18.3.sect1-1603.
Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 1 Mary Jane Massie, MD Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502.
Case and Commentary Feb 2005 Optional Treatments and Quality of Life, Commentary 2 Johannes Gobertus Meran, MD, MA Virtual Mentor. 2005;7(2):141-147. doi: 10.1001/virtualmentor.2005.7.2.ccas2-0502.
Case and Commentary Jul 2005 When Diagnosis Becomes Unaffordable, Commentary 1 William Hensel, MD Virtual Mentor. 2005;7(7):457-460. doi: 10.1001/virtualmentor.2005.7.7.ccas1-0507.
Case and Commentary Jul 2005 When Diagnosis Becomes Unaffordable, Commentary 2 Justin List, MAR Virtual Mentor. 2005;7(7):460-463. doi: 10.1001/virtualmentor.2005.7.7.ccas1-0507
Case and Commentary Aug 2005 Disclosing Error to a Patient: Physician-to-Patient Communication Geoffrey H. Gordon, MD Virtual Mentor. 2005;7(8):537-540. doi: 10.1001/virtualmentor.2005.7.8.ccas1-0508.
Case and Commentary Aug 2005 Hoping for the Best, Preparing for the Worst: Physician to Patient in Clinical Trial Frederic W. Platt, MD Virtual Mentor. 2005;7(8):541-546. doi: 10.1001/virtualmentor.2005.7.8.ccas2-0508.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 1 David S. Alberts, MD Virtual Mentor. 2004;6(11):477-479. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
Case and Commentary Nov 2004 Clinical Trials and End-of-Life Decision Making, Commentary 2 Lucy Godley, MD, PhD Virtual Mentor. 2004;6(11):479-481. doi: 10.1001/virtualmentor.2004.6.11.ccas1-0411.
State of the Art and Science Nov 2004 Chronic Myeloid Leukemia and the Application of Rational Drug Design Richard Maury Stone, MD Virtual Mentor. 2004;6(11):497-500. doi: 10.1001/virtualmentor.2004.6.11.cprl1-0411.